Oncternal Therapeutics Inc (ONCT)
8.80
+0.04
(+0.40%)
USD |
NASDAQ |
Apr 24, 16:00
8.80
0.00 (0.00%)
After-Hours: 18:01
Oncternal Therapeutics Price to Book Value: 0.8666 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 0.8632 |
April 22, 2024 | 0.842 |
April 19, 2024 | 0.8726 |
April 18, 2024 | 0.847 |
April 17, 2024 | 0.8814 |
April 16, 2024 | 0.8558 |
April 15, 2024 | 0.8666 |
April 12, 2024 | 0.9257 |
April 11, 2024 | 0.8804 |
April 10, 2024 | 0.8565 |
April 09, 2024 | 0.8489 |
April 08, 2024 | 0.8863 |
April 05, 2024 | 0.8519 |
April 04, 2024 | 0.8666 |
April 03, 2024 | 0.8863 |
April 02, 2024 | 0.9129 |
April 01, 2024 | 0.9159 |
March 28, 2024 | 0.8863 |
March 27, 2024 | 0.8076 |
March 26, 2024 | 0.7932 |
March 25, 2024 | 0.8086 |
March 22, 2024 | 0.8095 |
March 21, 2024 | 0.7839 |
March 20, 2024 | 0.8223 |
March 19, 2024 | 0.776 |
Date | Value |
---|---|
March 18, 2024 | 0.7682 |
March 15, 2024 | 0.7898 |
March 14, 2024 | 0.7701 |
March 13, 2024 | 0.8913 |
March 12, 2024 | 0.8863 |
March 11, 2024 | 0.9646 |
March 08, 2024 | 0.9444 |
March 07, 2024 | 0.911 |
March 06, 2024 | 0.9405 |
March 05, 2024 | 0.9356 |
March 04, 2024 | 1.00 |
March 01, 2024 | 0.9878 |
February 29, 2024 | 0.9159 |
February 28, 2024 | 0.9317 |
February 27, 2024 | 0.9514 |
February 26, 2024 | 0.912 |
February 23, 2024 | 0.8903 |
February 22, 2024 | 0.9061 |
February 21, 2024 | 0.8938 |
February 20, 2024 | 0.847 |
February 16, 2024 | 0.8293 |
February 15, 2024 | 0.8854 |
February 14, 2024 | 0.9041 |
February 13, 2024 | 0.9007 |
February 12, 2024 | 0.9548 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3078
Minimum
Apr 06 2023
15.65
Maximum
Dec 14 2020
2.291
Average
1.499
Median
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.644 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7160 |
Theriva Biologics Inc | 0.1673 |
Oragenics Inc | 3.129 |
Price to Book Value Related Metrics
Price | 8.80 |
Earnings Yield | -152.6% |
Market Cap | 26.04M |